Research Funding
- NIH Director's Early Independence Award
- NIH Director's New Innovator Award
- NIH Director's Pioneer Award
- NIH Director's Transformative Research Award
- Bridge to Artificial Intelligence (Bridge2AI) Program
- Illuminating the Druggable Genome Program
High-Risk Research: NIH Director's Early Independence Award Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| 2022 NIH Director's Early Independence Award (DP5) | 4/26/2021 | RFA-RM-21-018 | Becky Miller EarlyIndependence@mail.nih.gov 301-435-7204 |
Letter of Intent: 8/3/2021 Receipt Date: 9/3/2021 |
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | 11/16/2020 | PA-21-071 | Becky Miller earlyindependence@mail.nih.gov 301-594-9979 |
|
| Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) | 1/25/2018 | PA-18-592 | Becky Miller earlyindependence@mail.nih.gov 301-594-9979 |
High-Risk Research: NIH Director's New Innovator Award Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| 2022 NIH Director's New Innovator Award Program (DP2 Clinical Trial Optional) | 5/20/2021 | RFA-RM-21-016 | Ravi Basavappa, NewInnovatorAwards@mail.nih.gov 301 435-7204 |
8/20/2021 |
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | 11/16/2020 | PA-21-071 | Ravi Basavappa NewInnovatorAward@mail.nih.gov (301) 435-7204 |
|
| Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) | 1/25/2018 | PA-18-592 | Ravi Basavappa NewInnovatorAward@mail.nih.gov 301 435-7204 |
High-Risk Research: NIH Director's Pioneer Award Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| 2022 NIH Director’s Pioneer Award Program (DP1 Clinical Trial Optional) | 4/6/2021 | RFA-RM-21-015 | Ravi Basavappa PioneerAwards@mail.nih.gov 301-435-7204 |
9/10/2021 |
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | 11/16/2020 | PA-21-071 | Ravi Basavappa PioneerAwards@mail.nih.gov (301) 435-7204 |
|
| Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) | 1/25/2018 | PA-18-592 | Ravi Basavappa PioneerAwards@mail.nih.gov 301 435-7204 |
High-Risk Research: NIH Director's Transformative Award Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| 2022 NIH Directors Transformative Research Awards (R01 Clinical Trial Optional) | 6/4/2021 | RFA-RM-21-017 | Ravi Basavappa Transformative_Awards@mail.nih.gov (301) 435-7204 |
Receipt Date: 9/1/2021 |
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | 11/16/2020 | PA-21-071 | Ravi Basavappa Transformative_Awards@mail.nih.gov (301) 435-7204 |
|
| Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) | 1/25/2018 | PA-18-592 | Ravi Basavappa Transformative_Awards@mail.nih.gov (301) 435-7204 |
Illuminating the Druggable Genome Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Estimated Receipt Date |
|---|---|---|---|---|
| Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) | 4/1/2021 | RFA-RM-21-012 | Karlie Sharma DruggableGenome@mail.nih.gov 301-451-4965 |
Letter of Intent: 6/15/2021 Receipt Date: 7/15/2021 |
| Cutting Edge Informatics Tools for Illuminating the Druggable Genome (U01 Clinical Trial Not Allowed) | 4/5/2021 | RFA-RM-21-020 | Jerry Li DruggableGenome@mail.nih.gov 240-276-6210 |
Letter of Intent: 6/15/2021 Receipt Date: 7/15/2021 |
Bridge to Artificial Intelligence (Bridge2AI)
| Title | NIH Guide | RFA Number | Common Fund Contact | Estimated Receipt Date |
|---|---|---|---|---|
| 5/8/2021 | RFA-RM-21-023 | Shurjo Sen bridge2ai@od.nih.gov 301-827-7028 |
Letters of Intent: 30 days prior to the application due date Receipt Date: 8/20/2021 |
|
| Data Generation Projects for the NIH Bridge to Artificial Intelligence (Bridge2AI) Program (OT2) | 5/12/2021 | OTA-21-008 | Shurjo Sen bridge2ai@od.nih.gov 301-827-7028 |
Letters of Intent: 7/ 20/2021 Full proposals: 8/20/2021 |
Past Funding Opportunities
- 4D Nucleome
- Big Data to Knowledge
- Bioinformatics and Computational Biology
- Bridging Interventional Development Gaps (BrIDGs)
- Building Blocks, Biological Pathways and Networks
- Enhancing the Diversity of the NIH-Funded Workforce
- Epigenomics
- Extracellular RNA Communication
- Genotype-Tissue Expression (GTEx)
- Global Health
- Glycoscience
- Gulf Oil Spill
- HCS Research Collaboratory
- Health Economics
- High-Risk Research
- NIH Director’s Early Independence Award (EIA)
- NIH Director’s New Innovator Award
- NIH Director’s Pioneer Award
- NIH Director’s Transformative Research Awards
- Human Microbiome Project
- Illuminating the Druggable Genome
- Interdisciplinary Research
- Knockout Mouse Phenotyping
- Library of Integrated Network-Based Cellular Signatures (LINCS)
- Metabolomics
- Molecular Libraries and Imaging
- Nanomedicine
- NIH Center for Regenerative Medicine (NIH CRM)
- NIH Medical Research Scholars Program
- PROMIS: Patient-Reported Outcomes Measurement Information System
- Protein Capture Reagents
- Regulatory Science
- Science of Behavior Change
- Single Cell Analysis
- Stimulating Peripheral Activity to Relieve Conditions (SPARC)
- Strengthening the Biomedical Research Workforce
- Structural Biology
- Undiagnosed Diseases
Funded Research
- 4D Nucleome
- Big Data to Knowledge
- Bioinformatics and Computational Biology
- Bridging Interventional Development Gaps (BrIDGs)
- Building Blocks, Biological Pathways and Networks
- Enhancing the Diversity of the NIH-Funded Workforce
- Epigenomics
- Extracellular RNA Communication
- Gabriella Miller Kids First
- Genotype-Tissue Expression (GTEx)
- Global Health
- Glycoscience
- HCS Research Collaboratory
- Health Economics
- High-Risk Research:
- NIH Director’s Early Independence Award (EIA)
- NIH Director’s New Innovator Award
- NIH Director’s Pioneer Award
- NIH Director’s Transformative Research Awards
- Human Microbiome Project
- Illuminating the Druggable Genome
- Interdisciplinary Research
- Knockout Mouse Phenotyping
- Library of Integrated Network-Based Cellular Signatures (LINCS)
- Metabolomics
- Molecular Libraries and Imaging
- Molecular Transducers of Physical Activity in Humans
- Nanomedicine
- NIH Center for Regenerative Medicine (NIH CRM)
- NIH Medical Research Scholars Program
- PROMIS: Patient-Reported Outcomes Measurement Information System
- ProteinCapture Reagents
- Regulatory Science
- Science of Behavior Change
- Single Cell Analysis
- Stimulating Peripheral Activity to Relieve Conditions (SPARC)
- Strengthening the Biomedical Research Workforce
- Structural Biology
- Transformative High Resolution Cryo-Electron Microscopy
- Undiagnosed Diseases
This page last reviewed on June 21, 2021